Pushing the boundaries of innovation 

Breaking free from the status quo

The Advanced Diagnostics Laboratory promotes diagnostic innovation at Mayo Clinic. Our lab is a collaboration between Mayo Clinic’s Department of Laboratory Medicine & Pathology and the Center for Individualized Medicine designed to continue Mayo Clinic’s long tradition of innovation and pioneering diagnostics to improve care for patients.  

Our unique collaborative approach and atmosphere allows us to effectively partner on ideas and innovation in new diagnostic technologies both internally and with diagnostic companies outside of Mayo Clinic. We work hand in hand with our partners to identify, invest in, and develop differentiated services and products to help improve patient care both inside and outside of Mayo Clinic.

Innovation fueled by flexibility

In an ever-changing world, the Advanced Diagnostics Laboratory can be quickly and strategically modified to meet each project’s unique needs. This flexible approach to collaboration brings together different areas of expertise, different technologies, and different partners to pursue new ideas and help grow them beyond our own walls.

Examples include:

  • More than 100 specialists at Mayo Clinic helped develop the MayoComplete Solid Tumor Panel, the largest next-generation sequencing solid tumor panel offered by Mayo Clinic.
  • In collaboration with Thermo Fisher Scientific, we're bringing new solutions to patients by accelerating clinical validation and commercialization of selected next-generation sequencing, mass spectrometry, and immunology diagnostic tools.

The ability to form strategic partnerships with external companies while also working side by side with our own experts, colleagues, and clinicians from across Mayo Clinic allows us to be nimble and foster new diagnostic innovations.

At a glance…

We're dedicated to our patients' health and well-being,
and proud of the outstanding outcomes we achieve

9,000+

square feet of collaboration space

18

COVID-19 innovation projects completed within 1 year

23

active innovation projects, along with 25 innovation projects completed since inception

2

specialized collaboration laboratories

Interested in learning more? Connect with us.

More on innovation

Patient-focused pragmatism: The Mayo Clinic innovation model
April 13, 2022

In a world of ever-faster technical change, Mayo Clinic Laboratories is uniquely positioned to innovate. Collaboration with clinicians pinpoints unmet patient needs and facilitates the development of diagnostic testing that provides answers.
Communiqué
Every test tube connects to a patient: Quality control of specimens in the pre-analytic phase  
March 21, 2022

Each day, some 40 to 45 thousand specimens are shipped to Mayo Clinic Laboratories in Rochester, Minnesota, from hospitals and other health care organizations around the world. And for every sample, there’s a patient to whom it belongs, someone on the other end hoping for answers to a challenging, perhaps even life-threatening, condition.
Mass spectrometry-based assay detects viral antigens directly from clinical specimens
October 13, 2021

In a newly published study, a team from Mayo Clinic’s Advanced Diagnostics Laboratory has developed a mass spectrometry-based assay that’s able to detect COVID-19 (SARS-CoV-2) pathogens from human proteins with, remarkably, 98% sensitivity and 100% specificity. This is the first assay of its kind that can detect viral antigens “directly from clinical specimens” such as nasopharyngeal swabs. Mass spectrometry is a sensitive technique used to detect, identify, and quantitate molecules present in a sample.   
View MoreView Less